Does Vitamin K2 Fracture Risk Meta-Analysis work?

The current Migaku evidence database contains 2 reusable source documents for Vitamin K2 Fracture Risk Meta-Analysis. This answer focuses on strength of evidence and what the studies can or cannot prove. - The study used the Jadad scale and Cochrane Risk of Bias and GRADE criteria to evaluate study quality while the researchers used funnel plots and Egger's test to assess publication bias. [Lv C (2026); evidence level 1] - Results Interventions significantly improved BMD (SMD = 0.47; 95% CI: 0.31-0.62; p 2 = 79%), bone turnover markers (SMD = -0.69; 95% CI: -1.17 to -0.20; p = 0.004; I 2 = 99%), inflammation/oxidative stress markers (SMD = -1.34; 95% CI: -1.45 to -1.23; p 2 = 0%), and postoperative recovery/metabolic outcomes (SMD = -2.04; 95% CI: -2.31 to -1.77; p 2 = 86%). [Lv C (2026); evidence level 1] - Conclusion The study results demonstrate that nutritional and therapeutic treatments lead to better bone density results together with improved biochemical markers and reduced inflammation and faster recovery after surgery. [Lv C (2026); evidence level 1] - Background Nutritional and therapeutic methods are used to enhance bone health and assist in fracture healing while improving functional ability and reducing inflammation and bettering surgical results. [Lv C (2026); evidence level 1] - In the Global Burden of Disease 2019 analysis, low bone mineral density was associated with about 438,000 deaths and 166 million disability-adjusted life years, with large increases since 1990 (). [Zhang Zechen (2025); evidence level 1] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.